Rehabilitation With the Shoulder Pacemaker
1 other identifier
interventional
100
1 country
1
Brief Summary
The investigators purpose of the proposed study is to use the FDA approved Shoulder Pacemaker device in patients undergoing reverse shoulder arthroplasty and study the functional outcomes compared to a standard post-operative rehabilitation program. The investigators hypothesize that use of the Shoulder Pacemaker reduce pain and will allow for improved range of motion and function in patients undergoing RSA. The findings of this research may very well improve function in RSA patients through a novel, non-invasive approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 2, 2023
CompletedFirst Submitted
Initial submission to the registry
July 8, 2024
CompletedFirst Posted
Study publicly available on registry
July 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
October 29, 2025
October 1, 2025
3.9 years
July 8, 2024
October 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
American Shoulder and Elbow Surgeons score
Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
Pre-operatively
American Shoulder and Elbow Surgeons score
Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
6 weeks after surgery
American Shoulder and Elbow Surgeons score
Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
3 months after surgery
American Shoulder and Elbow Surgeons score
Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
6 months after surgery
American Shoulder and Elbow Surgeons score
Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
1 year after surgery
Study Arms (2)
Standard of care physical therapy
ACTIVE COMPARATORControl group and will not use the shoulder pacemaker, but will participate in a standardized physical therapy protocol for 3 months.
Shoulder pacemaker with physical therapy
EXPERIMENTALInclude a standardized physical therapy protocol with utilization of the Shoulder Pacemaker device 3 times per week over a 3-month period starting at 6 weeks post-operatively.
Interventions
Standard rehabilitation protocol for 3 months.
Standardized rehabilitation protocol with utilization of the shoulder pacemaker device 3 times per week over a 3-month period.
Eligibility Criteria
You may qualify if:
- Patients indicated for primary reverse shoulder arthroplasty
- Surgery at University of Utah Facilities
- Patients between the ages 18-80.
You may not qualify if:
- Prior ipsilateral shoulder arthroplasty
- Inability or unwillingness to participate in the rehabilitation protocol
- Prior cardiac pacemaker or spinal cord stimulator
- Age over 80
- History of periscapular surgery
- History of ipsilateral neurologic injury
- Prisoners
- Patients requiring prolonged immobilization deviating from standard protocol
- Patients who have an implantable medical device or other electrical device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Utah Orthopedics
Salt Lake City, Utah, 84108, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Joyce, M.D.
University of Utah Orthopaedics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
July 8, 2024
First Posted
July 15, 2024
Study Start
August 2, 2023
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
October 29, 2025
Record last verified: 2025-10